When we examined NOS2 expression in 3 breast cancer patient groups (all subtypes, basal-like, and ER-/PR-) we found that high NOS2 expression was associated with decreased overall survival (confirming previous reports27) (Fig. 4a). The gene discussed is NOS2; the disease is breast carcinoma.